RSV INFECTION
Clinical trials for RSV INFECTION explained in plain language.
Never miss a new study
Get alerted when new RSV INFECTION trials appear
Sign up with your email to follow new studies for RSV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nose drop vaccines aim to protect kids from RSV
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested two experimental RSV vaccines given as nose drops in 60 children. Some children already had RSV antibodies (ages 1 to 5) and some did not (ages 6 months to 2 years). The main goal was to check if the vaccines were safe and triggered an immune respons…
Matched conditions: RSV INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 05:46 UTC
-
New combo vaccine aims to shield seniors from two respiratory viruses
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new vaccine designed to protect against two respiratory viruses: RSV and hMPV. It involved 385 healthy adults aged 60 to 75 who received a single shot of different vaccine doses. The main goals were to check the vaccine's safety and see how well it…
Matched conditions: RSV INFECTION
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 04, 2026 16:21 UTC
-
New RSV pill shows promise in early trial
Disease control CompletedThis study tested an experimental oral drug called EDP-323 in 142 healthy adults who were intentionally infected with RSV. The goal was to see if the drug is safe and can reduce the amount of virus in the body compared to a placebo. The trial is complete, but results are not yet …
Matched conditions: RSV INFECTION
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New RSV shot shows promise for protecting vulnerable babies
Prevention CompletedThis study tested a new medicine called clesrovimab in over 1,000 infants and children at high risk for severe RSV infection. The goal was to see if it is safe and works as well as an existing treatment, palivizumab. Participants received either the new drug or the standard one, …
Matched conditions: RSV INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated May 13, 2026 15:58 UTC
-
RSV immunity under the microscope: study targets vaccine hurdles in seniors
Knowledge-focused CompletedThis study looked at how the immune system of older adults (ages 60-75) responds to the respiratory syncytial virus (RSV). Researchers exposed 28 healthy volunteers to a controlled dose of RSV to track their immune reactions and any side effects. The goal was to find better targe…
Matched conditions: RSV INFECTION
Phase: NA • Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated May 17, 2026 05:33 UTC